|
FDA Approval Activities for this Drug…
Innohep (tinzaparin sodium) Injection, Bristol-Myers Squibb Pharma Company NDA 20-484/S-002 2/5/02 4/17/02
Innohep (tinzaparin sodium) Injection, Dupont Pharmaceutical Company NDA 20-484 7/14/00 7/24/00 7/24/00 4/9/02
Innohep Indications: for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium.
Back to this API's Main Page.
|
